President & CEO of Laboratory Corp Of America Holdings (30-Year Financial, Insider Trades) David P King (insider trades) sold 30,177 shares of LH on 10/28/2019 at an average price of $165.4 a share. The total sale was $5 million.
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development. Laboratory Corp of America Holdings has a market cap of $16.2 billion; its shares were traded at around $166.28 with a P/E ratio of 21.87 and P/S ratio of 1.43. Laboratory Corp of America Holdings had annual average EBITDA growth of 7.30% over the past ten years. GuruFocus rated Laboratory Corp of America Holdings the business predictability rank of 5-star. GuruFocus has detected 3 severe warning signs with Laboratory Corp of America Holdings. .
CEO Recent Trades:
- President & CEO David P King sold 30,177 shares of LH stock on 10/28/2019 at the average price of $165.4. The price of the stock has increased by 0.53% since.
For the complete insider trading history of LH, click here
.